BMY
73
-3
AXP
67
-4
COF
65
-4
AMP
67
-3
CLX
55
3
AA
70
-3
DD
38
-2
BDX
59
-2
CA
30
-6
CVX
32
3
AEP
67
3
APH
56
-2
CF
38
2
CMA
64
-3
EBAY
59
3
CAG
41
5
BBY
43
-3
APD
54
2
AZO
42
-3
CFG
89
-4
BMY
73
-3
AXP
67
-4
COF
65
-4
AMP
67
-3
CLX
55
3
AA
70
-3
DD
38
-2
BDX
59
-2
CA
30
-6
CVX
32
3
AEP
67
3
APH
56
-2
CF
38
2
CMA
64
-3
EBAY
59
3
CAG
41
5
BBY
43
-3
APD
54
2
AZO
42
-3
CFG
89
-4
Financhill
Back

Novonesis (Novozymes A/S) 10K Form

Buy
58

NVZMY
Novonesis (Novozymes A/S)

Last Price:
$64.08
Seasonality Move:
3.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVZMY News And Ratings

See the #1 stock for the next 7 days that we like better than NVZMY

NVZMY Financial Statistics

Sales & Book Value

Annual Sales: $4.1B
Cash Flow: $53.9M
Price / Cash Flow: 41.24
Annual Sales: $26.07
Price / Book: 2.66

Profitability

EPS (TTM): 1.13730
Net Income (TTM): $522.7M
Gross Margin: $1.8B
Return on Equity: 6.56%
Return on Assets: 3.97%

Novonesis (Novozymes A/S) Earnings Forecast

Key Novonesis (Novozymes A/S) Financial Ratios

  • The Gross Profit Margin over the past 26 years for NVZMY is 42.48%.
  • The Selling, General & Administrative Expenses for NVZMY have been equal to 19.97% of Gross Profit Margin.
  • The Research & Development expenses have been 8.70% of Revenue.
  • The Interest Expense is 28.65% of Operating Income.
  • The Net Earning history of NVZMY is 7.98% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 20 years.

Novonesis (Novozymes A/S) Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Chemicals
Sector: Materials
Current Symbol: NVZMY
Website: novonesis.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 1.66
Quick Ratio: 1.04

Price-to-Earnings

Trailing P/E Ratio: 88.77
Forward P/E Ratio: 0

NVZMY Technical Analysis vs Fundamental Analysis

Buy
58
Novonesis (Novozymes A/S) (NVZMY) is a Buy

Is Novonesis (Novozymes A/S) a Buy or a Sell?